---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-011344"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:53:56.835005+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biotricity raises $1M in private placement of Series B Preferred Stock, with option for additional $1M

## Summary
- Gross proceeds of $1M from sale of 110 Series B Convertible Preferred shares at $9,090.91 each.
- Company has 30-day option to require second closing for additional $1M (110 more shares).
- Series B Preferred Stock: 8% cumulative dividend (15% upon triggering event), initial conversion price $3.50, alternate conversion at 80% of lowest VWAP.
- Registration rights agreement requires filing registration statement within 45 days; failure triggers issuance of 100,000 common shares.
- Voting agreement with certain stockholders to support Nasdaq-required stockholder approval for conversion shares issuances.

## SEC filing metadata
- accession: 0001493152-24-011344
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/0001493152-24-011344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-011344
- JSON: https://secwatch.observer/filing/0001493152-24-011344.json
- Plain text: https://secwatch.observer/filing/0001493152-24-011344.txt

## Key facts
- Material Agreements
  BIOTRICITY INC. entered into Purchase Agreement with an institutional investor (effective 2024-03-25).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an institutional investor
  - Effective: 2024-03-25
  source text: On March 25, 2024, Biotricity Inc. (the “Company”) entered into a security purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the issuance and sale, in a private placement offering (the “Private Placement”), of 110 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value (the “Series B Preferred Stock”), at a purchase price of $9,090.91 per share of Series B Convertible Preferred Stock, for gross proceeds of $1,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/0001493152-24-011344-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.